Author:
Maghsoudi Kaveh,Braunstein Steve E.,Yuen Florence
Publisher
Springer International Publishing
Reference21 articles.
1. Cancer Facts and Figs. 2015. American Cancer Society. 2015. http://www.cancer.org/acs/groups/content/@editorial/documents/document/acspc-044552.pdf . Accessed 29 April 2015.
2. Surveillance, Epidemiology, and End Results Program, Cancer Statistics Review 1975–2012. National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services. 2009. http://seer.cancer.gov/data/ . Accessed 26 June 2015.
3. Mohammed N, Kestin L, Ghilezan M, Krauss D, Vicini F, Brabbins D, et al. Comparison of acute and late toxicities for three modern high-dose radiation treatment techniques for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2012;82:204–12. doi: 10.1016/j.ijrobp.2010.10.009 .
4. Ryu JK, Winter K, Michalski JM, Purdy JA, Markoe AM, Earle JD, et al. Interim report of toxicity from 3D conformal radiation therapy (3D-CRT) for prostate cancer on 3DOG/RTOG 9406, level III (79.2 Gy). Int J Radiat Oncol Biol Phys. 2002;54:1036–46.
5. Zelefsky MJ, Fuks Z, Hunt M, Yamada Y, Marion C, Ling CC, et al. High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys. 2002;53:1111–6.